BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27455134)

  • 1. Regional hyperthermia for high-risk soft tissue sarcoma treatment: present status and next questions.
    Issels R; Lindner LH
    Curr Opin Oncol; 2016 Sep; 28(5):447-52. PubMed ID: 27455134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current trials and new aspects in soft tissue sarcoma of adults.
    Issels RD; Schlemmer M
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S4-8. PubMed ID: 12042982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional hyperthermia in high-risk soft tissue sarcomas.
    Issels RD
    Curr Opin Oncol; 2008 Jul; 20(4):438-43. PubMed ID: 18525341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial.
    Issels RD; Lindner LH; Verweij J; Wessalowski R; Reichardt P; Wust P; Ghadjar P; Hohenberger P; Angele M; Salat C; Vujaskovic Z; Daugaard S; Mella O; Mansmann U; Dürr HR; Knösel T; Abdel-Rahman S; Schmidt M; Hiddemann W; Jauch KW; Belka C; Gronchi A;
    JAMA Oncol; 2018 Apr; 4(4):483-492. PubMed ID: 29450452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter study.
    Angele MK; Albertsmeier M; Prix NJ; Hohenberger P; Abdel-Rahman S; Dieterle N; Schmidt M; Mansmann U; Bruns CJ; Issels RD; Jauch KW; Lindner LH
    Ann Surg; 2014 Nov; 260(5):749-54; discussion 754-6. PubMed ID: 25379845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas.
    Wendtner CM; Abdel-Rahman S; Krych M; Baumert J; Lindner LH; Baur A; Hiddemann W; Issels RD
    J Clin Oncol; 2002 Jul; 20(14):3156-64. PubMed ID: 12118030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative chemotherapy and regional hyperthermia for high-risk adult-type soft tissue sarcomas.
    Lindner LH; Blay JY; Eggermont AMM; Issels RD
    Eur J Cancer; 2021 Apr; 147():164-169. PubMed ID: 33684876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-risk soft tissue sarcoma: clinical trial and hyperthermia combined chemotherapy.
    Issels RD
    Int J Hyperthermia; 2006 May; 22(3):235-9. PubMed ID: 16754344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study.
    Issels RD; Abdel-Rahman S; Wendtner C; Falk MH; Kurze V; Sauer H; Aydemir U; Hiddemann W
    Eur J Cancer; 2001 Sep; 37(13):1599-608. PubMed ID: 11527684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of radiological and pathohistological response to neoadjuvant chemotherapy combined with regional hyperthermia (RHT) and study of response dependence on the applied thermal parameters in patients with soft tissue sarcomas (STS).
    Stahl R; Wang T; Lindner LH; Abdel-Rahman S; Santl M; Reiser MF; Issels RD
    Int J Hyperthermia; 2009 Jun; 25(4):289-98. PubMed ID: 19670096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative systemic etoposide/ifosfamide/doxorubicin chemotherapy combined with regional hyperthermia in high-risk sarcoma: a pilot study.
    Issels RD; Bosse D; Abdel-Rahman S; Starck M; Panzer M; Jauch KW; Stiegler H; Berger H; Sauer H; Peter K
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S233-7. PubMed ID: 8453705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of hyperthermia in combined treatment in the management of soft tissue sarcoma.
    Issels RD; Schlemmer M; Lindner LH
    Curr Oncol Rep; 2006 Jul; 8(4):305-9. PubMed ID: 17254531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia.
    Wendtner C; Abdel-Rahman S; Baumert J; Falk MH; Krych M; Santl M; Hiddemann W; Issels RD
    Eur J Cancer; 2001 Sep; 37(13):1609-16. PubMed ID: 11527685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional hyperthermia combined with chemotherapy in paediatric, adolescent and young adult patients: current and future perspectives.
    Seifert G; Budach V; Keilholz U; Wust P; Eggert A; Ghadjar P
    Radiat Oncol; 2016 Apr; 11():65. PubMed ID: 27138749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthermia as an adjunctive treatment for soft-tissue sarcoma.
    Pennacchioli E; Fiore M; Gronchi A
    Expert Rev Anticancer Ther; 2009 Feb; 9(2):199-210. PubMed ID: 19192958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults.
    Fiegl M; Schlemmer M; Wendtner CM; Abdel-Rahman S; Fahn W; Issels RD
    Int J Hyperthermia; 2004 Sep; 20(6):661-70. PubMed ID: 15370821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET response criteria in solid tumors predicts progression-free survival and time to local or distant progression after chemotherapy with regional hyperthermia for soft-tissue sarcoma.
    Fendler WP; Lehmann M; Todica A; Herrmann K; Knösel T; Angele MK; Dürr HR; Rauch J; Bartenstein P; Cyran CC; Hacker M; Lindner LH
    J Nucl Med; 2015 Apr; 56(4):530-7. PubMed ID: 25722445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
    Kasper B; Ouali M; van Glabbeke M; Blay JY; Bramwell VH; Woll PJ; Hohenberger P; Schöffski P
    Eur J Cancer; 2013 Jan; 49(2):449-56. PubMed ID: 22975215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthermia in soft tissue sarcoma.
    Lindner LH; Issels RD
    Curr Treat Options Oncol; 2011 Mar; 12(1):12-20. PubMed ID: 21360087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.